Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-06-11
Original SEC Filing: Click here

---

Webplus: SVA/20200611/6-K/2_EX-99.1/000.htm SEC Original: tm2022386d1_ex99-1.htm
Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III Beijing (China), Sao Paulo, (Brazil), June 11th, 2020 Science Sinovac has made significant progress in the development of CoronaVac. Promising preclinical results regarding CoronaVac were recently published in the peer-reviewed academic journal Through this collaboration, Instituto Butantan will sponsor Phase III

---

---

Webplus: SVA/20200611/6-K/1/000.htm SEC Original: tm2022386d1_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-06-11CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200